# Immunogenicity and Safety of Liquid Bivalent Oral Poliomyelitis Vaccine

> **NCT02434770** · PHASE3 · COMPLETED · sponsor: **PATH** · enrollment: 750 (actual)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** BBIBP Bivalent Oral Poliomyelitis Vaccine Lot 1
- **BIOLOGICAL:** BBIBP Bivalent Oral Poliomyelitis Vaccine Lot 2
- **BIOLOGICAL:** BioFarma Bivalent Oral Poliomyelitis Vaccine

## Key facts

- **NCT ID:** NCT02434770
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2016-06-17
- **Final completion:** 2016-06-17
- **Target enrollment:** 750 (ACTUAL)
- **Last updated:** 2020-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02434770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02434770, "Immunogenicity and Safety of Liquid Bivalent Oral Poliomyelitis Vaccine". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02434770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*